Market cap
$12 Mln
Recently Viewed
Clear All$0.56
$0.00
(-0.43%)
As on 30-Apr-2026 10:23EDT
Market cap
$12 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
2.7
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-- Mln
ROE
-1.6 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
28.7
Debt to Equity
0.7
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
18,785,750
CFO
S$--
EBITDA
S$--
Net Profit
S$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
| 13.8 | 3.9 | -29.6 | -86.7 | -- | -- | -- |
|
BSE Sensex
| -9.2 | 6.9 | -6.5 | -4.2 | 8.0 | 9.1 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery,... foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore. Read more
Group CEO & Director
Mr. Wai Man Cheung
Executive Chairman of the Board
Mr. Keng Leong Fung
Headquarters
Singapore
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Basel Medical Group Ltd Ordinary Shares (BMGL) is $0.56 (NASDAQ) as of 30-Apr-2026 10:23 EDT. Basel Medical Group Ltd Ordinary Shares (BMGL) has given a return of -86.66% in the last 1 years.
Since, TTM earnings of Basel Medical Group Ltd Ordinary Shares (BMGL) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2025
|
--
|
--
|
The 52-week high and low of Basel Medical Group Ltd Ordinary Shares (BMGL) are Rs 9.40 and Rs 0.49 as of 30-Apr-2026.
Basel Medical Group Ltd Ordinary Shares (BMGL) has a market capitalisation of $ 12 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Basel Medical Group Ltd Ordinary Shares (BMGL), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.